Recent Posts - page 2
-
Thyroid hormone journey: Metabolism
As one follows the thyroid hormone journey through the human body, at a crucial stage inside many of our cells, a beautiful and complex cascade transforms our thyroid hormones. Three deiodinase enzymes, types 1, 2 and 3 (D1, D2, D3),… Read More ›
-
Finkler, 1959: Liothyronine as a replacement for thyroid therapy
One of Thyroid Patients Canada’s values is to bring to light little-known aspects of the history of thyroid therapy so that it can open minds about future possibilities. The history of L-T3 (Liothyronine) monotherapy brings to light the flexibility and… Read More ›
-
Thyroid Patients Canada: Looking back on 2020, entering 2021
The year 2020 has been a productive year for our organization of thyroid patients and our website, despite the challenges we all faced on a global scale. In this post, HIGHLIGHTS: I’ll briefly mention our organizational milestones of the year…. Read More ›
-
Christmas 2020: Hope and cheer for thyroid patients
It’s been quite a year, so we send you good cheer. This season may be a socially-distanced experience for many of you, but still, you are not alone. We’re stronger together. We’re going to keep advancing thyroid science & policy,… Read More ›
-
Ingbar and Braverman’s historic study of LT4 monotherapy
As part of my post on “The thyroid gland is a T3 shield,” I reviewed a research article by Ingbar and team from 1982. Wow. What a treasure. The title of this article is “Elevated serum thyroxine concentration in patients… Read More ›
-
Reverse T3 in the context of health status, dosages, and thyroid levels
A collection of research graphs and quotations showing diverse Reverse T3 levels coexisting with health, in various illnesses, and alongside various T3 and T4 levels.
-
Gullo: LT4 monotherapy and thyroid loss invert FT3 and FT4 per unit of TSH
In 2011, Gullo’s research team published a landmark study in thyroid therapy titled “Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients.” Gullo and colleagues examined the TSH, FT3 and FT4 levels and the FT3:FT4 ratios of 1,811 thyroidless patients… Read More ›
-
Normal FT3:FT4 thyroid hormone ratios in large populations
A normal ratio of Free T3 (FT3) to Free T4 (FT4) thyroid hormones appears to be a basic principle in thyroid hormone economy when no thyroid hormone dosing and no disease interfere. When measured in pmol/L, the ratio is consistent… Read More ›
Featured Categories
Therapy paradigms ›
-
Mimicry: The idol of T3-T4 combo therapy 2004-2014
September 10, 2020
-
The foundations of synthetic T3-T4 therapy in the 1990s
September 1, 2020
-
Four definitions of thyroid status
March 28, 2020
-
Biochemical bigotry: Enforcing normalized thyroid lab results
February 15, 2020
-
Relational Stability, part 4: The new thyroid paradigm
December 16, 2019
Research Reviews ›
-
Ingbar and Braverman’s historic study of LT4 monotherapy
December 21, 2020
-
Prevalence rates for 10 chronic disorders at various FT4, TSH and FT3 levels
October 21, 2020
-
Japanese thyroid scientists examine symptoms in relation to FT3 and TSH
March 11, 2020
-
Relational Stability, part 3: Shifting TSH-T4-T3 relationships
December 16, 2019
-
Relational Stability, Part 2: Normality of TSH and thyroid hormones
December 15, 2019
Testing policy ›
-
How can clinical biochemists help or harm thyroid patients?
March 2, 2020
-
Survey: Canadian Thyroid Testing Tips & Challenges
December 19, 2019
-
In 1981, Canadian physicians argued T3 was the best test in thyroid therapy
December 10, 2019
-
2019 ATA article engages in patient-blaming and doctor-shaming
December 2, 2019
-
Caution: Doctors perform T3-ectomies without our consent
November 23, 2019